NMS-03305293

· Nerviano Medical Sciences

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NMS-03305293, covering 2024-09-19 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer [Phase 1]